Location History:
- San Diego, CA (US) (2011 - 2012)
- Chula Vista, CA (US) (2007 - 2015)
- La Jolla, CA (US) (2021)
Company Filing History:
11 out of 15,541 
3 out of 7 
1 out of 202 
Years Active: 2007-2021
Title: Edward Rockenstein: Innovator in Neurodegenerative Disorder Treatments
Introduction
Edward Rockenstein is a prominent inventor based in Chula Vista, California. He has made significant contributions to the field of neurodegenerative disorders, holding a total of 14 patents. His work focuses on developing innovative treatments for conditions such as Alzheimer's Disease and other taupathies.
Latest Patents
Rockenstein's latest patents include compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders. These compositions consist of antibodies, including single chain antibodies, that specifically target 3-repeat (3R) Tau. This innovation aims to treat taupathies such as Alzheimer's Disease, Pick's Disease, and Fronto-temporal lobar degeneration. Additionally, he has developed methods for diagnosing neurodegenerative disorders associated with 3R Tau accumulation. Another significant patent involves improved agents and methods for treating diseases related to synucleinopathic conditions, particularly Parkinson's disease. These methods focus on administering agents that induce a beneficial immunogenic response against Lewy bodies in the brain.
Career Highlights
Throughout his career, Rockenstein has worked with esteemed institutions, including the University of California and Neotope Biosciences Limited. His research has been pivotal in advancing the understanding and treatment of neurodegenerative diseases.
Collaborations
Some of his notable coworkers include Eliezer Masliah and Dale Bernard Schenk, who have collaborated with him on various research projects.
Conclusion
Edward Rockenstein's innovative work in the field of neurodegenerative disorders has the potential to significantly impact the treatment landscape for conditions like Alzheimer's Disease and Parkinson's disease. His contributions continue to pave the way for future advancements in medical science.